With your own knowledge and the help of the following document:

Document 1 (Title: Pathophysiology of Glomerular Filtration Barrier Disruption): Nephrotic syndrome represents a characteristic clinical constellation resulting from increased glomerular permeability to plasma proteins, with distinctive laboratory and clinical manifestations reflecting fundamental pathophysiological processes. Proteinuria exceeding 3.5g/24hr in adults constitutes the defining laboratory abnormality, representing the primary manifestation of glomerular filtration barrier dysfunction across diverse etiologies including minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. Biochemical analysis demonstrates that this protein loss predominantly comprises albumin due to its abundance and physicochemical properties, resulting in characteristic hypoalbuminemia when urinary losses exceed hepatic synthetic capacity. This albumin depletion leads to reduced plasma oncotic pressure with consequent fluid redistribution from intravascular to interstitial compartments. Total serum protein measurements invariably demonstrate reduction, typically below 60g/L, reflecting both albumin depletion and losses of other plasma proteins including immunoglobulins, clotting factors, and hormone-binding proteins. These protein alterations produce characteristic changes in serum protein electrophoresis patterns, with alpha-2 globulin fractions demonstrating increased percentage contribution to the protein profile due to relative preservation of larger proteins including alpha-2-macroglobulin compared to smaller proteins more readily filtered through the damaged glomerular barrier. Systemic blood pressure frequently demonstrates complex patterns depending on underlying etiology, with hypertension commonly accompanying nephrotic syndrome associated with primary glomerulonephritides, though not representing a fundamental component of pure nephrotic physiology itself. Renal function parameters including serum creatinine and glomerular filtration rate typically remain preserved in uncomplicated nephrotic syndrome, distinguishing it from nephritic presentations, though progressive decline may accompany specific etiologies or represent complications of prolonged nephrotic states through secondary focal segmental glomerulosclerosis development.
Document 2 (Title: Diagnostic Approach to Preeclampsia): Hypertensive disorders complicate 5-10% of pregnancies and contribute significantly to maternal and perinatal morbidity and mortality worldwide. Preeclampsia, a pregnancy-specific multisystem disorder characterized by hypertension and end-organ dysfunction after 20 weeks gestation, affects approximately 3-5% of pregnancies. Early detection through regular prenatal assessments remains crucial for optimizing maternal and fetal outcomes. The contemporary diagnostic criteria for preeclampsia focus on both blood pressure parameters and evidence of maternal organ dysfunction. Hypertension, defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on two occasions at least four hours apart, represents the fundamental requirement. Proteinuria, historically considered mandatory for diagnosis, is now recognized as just one of several possible indicators of end-organ involvement. Quantification of urinary protein excretion through 24-hour urine collection remains the gold standard assessment, with significant proteinuria defined as ≥300 mg in 24 hours or a protein/creatinine ratio ≥0.3 mg/dL in a random sample. Other laboratory evaluations, including liver function tests and coagulation studies, help assess hepatic involvement and potential HELLP syndrome (hemolysis, elevated liver enzymes, low platelets). Leukocytosis may occur but lacks specificity for preeclampsia. Clinical manifestations often include rapid weight gain and generalized edema, particularly facial and periorbital, distinguishing it from dependent edema commonly observed in normal pregnancy. Progressive symptoms including headache, visual disturbances, and epigastric pain suggest impending eclampsia, necessitating urgent intervention.
Document 3 (Title: Nitroglycerin): Abstract: 1 Blood pressure, systemic arterial compliance, and diameter, blood flow velocity, volumic flow and impedance of the brachial artery were measured before and after intravenous administration of nitroglycerin (15 micrograms/min during 15 min) in 11 patients with sustained essential hypertension. 2 For the evaluation of the diameter of the brachial artery, a bidimensional pulsed Doppler was used, enabling the angle of the ultrasound beam relative to the flowing stream of blood to be measured with an error of less than 2%. 3 After nitroglycerin, systolic pressure significantly decreased (P less than 0.01) without significant change in diastolic and mean arterial pressures, cardiac index, stroke index and total peripheral resistance. 4 Systemic arterial compliance and brachial artery diameter significantly increased (P less than 0.001; P less than 0.01) while velocity and blood flow of the brachial artery were unchanged. 5 The pattern of the input impedance of the brachial artery was consistent with a predominant effect of nitroglycerin on the viscoelastic properties of peripheral large arteries. 6 The study provided evidence that, in hypertensive patients, nitroglycerin has a direct effect on peripheral large arteries, causing an increase in arterial diameter and compliance, thus leading to a predominant decrease in systolic pressure.

Answer the following list question.
Question: Which of the following signs or symptoms is/are part of pure nephrotic syndrome?
Options:
1. Proteinuria
2. Arterial hypertension
3. Decreased serum albumin
4. Decreased total serum proteins
5. Increased percentage of alpha-2 globulins on electrophoresis

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.